📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Baronova

1.1 - Company Overview

Baronova Logo

Baronova

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage medical devices under development to induce weight loss through non-surgical, non-pharmacologic approaches.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Baronova

Madrigal Pharmaceuticals Logo

Madrigal Pharmaceuticals

HQ: United States Website
  • Description: Provider of THR-β-selective agonist therapy for NASH, a once-daily, oral, liver-directed treatment granted accelerated approval by the U.S. FDA. Offers multiple Phase 3 clinical trials in NASH, including in patients with compensated cirrhosis; conducts NASH/MASH R&D focused on the THR-β pathway; and supports educational programs for healthcare professionals on NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Madrigal Pharmaceuticals company profile →
Rediscovery Life Sciences Logo

Rediscovery Life Sciences

HQ: United States Website
  • Description: Provider of biopharma drug development, creating medicines with less risk through drug repurposing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rediscovery Life Sciences company profile →
Neurocrine Biosciences Logo

Neurocrine Biosciences

HQ: United States Website
  • Description: Provider of therapies for neurological and endocrine-related diseases, including FDA-approved Ingrezza (valbenazine) for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa and Oriahnn (commercialized by AbbVie) for endometriosis pain and heavy menstrual bleeding associated with uterine fibroids; and investigational Crinecerfont for congenital adrenal hyperplasia due to 21-hydroxylase deficiency, NBI-1065890 (VMAT2 inhibitor), and NBI-1065845 (AMPA potentiator).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neurocrine Biosciences company profile →
Millendo Therapeutics Logo

Millendo Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development, previously primarily focused on developing novel treatments for endocrine diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Millendo Therapeutics company profile →
Ilypsa Logo

Ilypsa

HQ: United States Website
  • Description: Provider of renal care pharmaceutical products, discovering, developing, manufacturing, and delivering human therapeutics, including non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. Formerly known as Symyx Therapeutics, Inc., founded in 2002 and based in Santa Clara, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ilypsa company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Baronova

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Baronova

2.2 - Growth funds investing in similar companies to Baronova

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Baronova

4.2 - Public trading comparable groups for Baronova

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Baronova

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Baronova

What does Baronova do?

Baronova is a provider of clinical-stage medical devices under development to induce weight loss through non-surgical, non-pharmacologic approaches.

Who are Baronova's competitors?

Baronova's competitors and similar companies include Madrigal Pharmaceuticals, Rediscovery Life Sciences, Neurocrine Biosciences, Millendo Therapeutics, and Ilypsa.

Where is Baronova headquartered?

Baronova is headquartered in United States.

How many employees does Baronova have?

Baronova has 1,000 employees 🔒.

When was Baronova founded?

Baronova was founded in 2010 🔒.

What sector and industry vertical is Baronova in?

Baronova is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Baronova

Who are the top strategic acquirers in Baronova's sector and industry

Top strategic M&A buyers and acquirers in Baronova's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Baronova?

Top strategic M&A buyers groups and sectors for Baronova include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Baronova's sector and industry vertical

Which are the top PE firms investing in Baronova's sector and industry vertical?

Top PE firms investing in Baronova's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Baronova's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Baronova's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Baronova's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Baronova include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Baronova's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Baronova?

The key public trading comparables and valuation benchmarks for Baronova include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Baronova for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Baronova with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Baronova's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Baronova with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Baronova's' sector and industry vertical?

Access recent funding rounds and capital raises in Baronova's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Baronova